News

Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities Ltd * Medanta’s expansion is far from over. We forecast its net cash balance to be INR 10bn+ by end-FY26 (based on current expansion plan) implying potential for more capex initiatives in the near future. This expansion could be in UP/ Punjab, as alluded to by the management earlier. Medanta’s Lucknow and Patna facilities have performed exceptionally well and that trend will continue as they achieve full-scale capacity over the next 2-3 years, in our view. In addition, if Noida’...
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities Ltd
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities Ltd
Source: JM Financial Institutional Securities Ltd
7/09/2023 2:56:20 PM
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities Medanta’s 4Q earnings surprised positively driven by better EBITDA margins and higher other income coupled with lower tax rate. Medanta has delivered Revenue/EBITDA/PAT CAGR of 36%/79%/237% respectively over FY21-23. We see new hospitals contribute 33% to revenues in FY23 (vs. 10% in FY19). The new hospitals have ramped-up exceptionally well lending a strong support to overall earnings growth which we expect to sustain. They continue to optically lower the overall ARPOB and occupancy le...
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities
Source: JM Financial Institutional Securities
20/06/2023 3:52:21 PM
Buy Global Health Limited For Target Rs. 575 - JM Financial Institutional Securities Impressive margin performance Medanta’s earnings are tracking well ahead of JMFe on FY23 basis. ARPOBs grew 9%YoY to INR 58494 for 9M driven by better specialty mix and lower internal medicine. This also resulted in gross margin improvement by 180bps YoY to 77.3%. ALOS has normalized while occupancy levels have been trending ~59% (in line with estimates) with scope to improve as newer beds gradually ramp up. New hospital revenues are tracking well ahead of estimates with Patna turnin...
Buy Global Health Limited For Target Rs. 575 - JM Financial Institutional Securities
Buy Global Health Limited For Target Rs. 575 - JM Financial Institutional Securities
Source: JM Financial Institutional Securities
23/02/2023 2:14:21 PM
No 'male disadvantage' when it comes to Covid-heart disease link The so-called 'male disadvantage' in severity of Covid-19 cannot solely be explained by pre-existing cardiovascular disease as other factors also contribute to heart disease severity, researchers now say. Covid-19 is a deadly respiratory illness, but cardiovascular complications such as irregular heart beat (arrhythmia), lack of blood flow to the brain (stroke) and heart failure are also reported in some patients. Men typically have worse outcomes from Covid-19 than women. As...
No 'male disadvantage' when it comes to Covid-heart disease link
No 'male disadvantage' when it comes to Covid-heart disease link
Source: IANS
14/02/2023 2:32:35 PM
IPO Note : Global Health International Ltd By Swastika Investmart Incorporated in 2004, Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Under the “Medanta” brand, Company has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one ho...
IPO Note : Global Health International Ltd By Swastika Investmart
IPO Note : Global Health International Ltd By Swastika Investmart
Source: Swastika Investmart Ltd
2/11/2022 4:57:02 PM
Global Health Ltd's IPO to open up on Thursday, price band Rs 319-336 per equity share Global Health Ltd, that operates a network of five hospitals under the brand name Medanta, will open its initial public offering on November 3 and the offer will close on November 7. There are five Medanta Hospitals in Gurugram, Indore, Ranchi, Lucknow and Patna and one in under construction in Noida. The price band of the offer has been fixed at Rs 319 to 336 per equity share of face value Rs 2 each. The bids can be made for a minimum of 44 equity shares and in multiples of 44 equity s...
Global Health Ltd's IPO to open up on Thursday, price band Rs 319-336 per equity share
Global Health Ltd's IPO to open up on Thursday, price band Rs 319-336 per equity share
Source: IANS
1/11/2022 5:29:02 PM
IPO Note : Global Health Ltd By Choice Broking Global Health Ltd : SUBSCRIBE Salient features of the IPO: • Global Health Ltd. (Global Health), which operates and manages hospitals under the “Medanta” brand, is coming up with an IPO to raise around Rs. 2,200cr, which opens on 3rd Nov. and closes on 7th Nov. 2022. The price band is Rs. 319 - 336 per share. • The IPO is a combination of fresh issue and OFS portion. Global Health will not receive any proceeds from the OFS portion. Of the fresh issue net pr...
IPO Note : Global Health Ltd By Choice Broking
IPO Note : Global Health Ltd By Choice Broking
Source: Choice Broking Pvt Ltd
30/10/2022 3:20:22 PM